Načítá se...
Rituximab-associated Hypogammaglobulinemia in pediatric patients with autoimmune diseases
BACKGROUND: Despite the increased use of rituximab in treating pediatric patients with autoimmune diseases in the last decade, there are limited data on rituximab safety in those subjects who have a developing immune system. The objective of this study is to determine the prevalence of hypogammaglob...
Uloženo v:
| Vydáno v: | Pediatr Rheumatol Online J |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6712749/ https://ncbi.nlm.nih.gov/pubmed/31462263 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-019-0365-y |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|